Novo Nordisk: Raised its 2026 earnings forecast, expecting full-year adjusted sales to decline by 4% to 12% year-on-year, up from the previous forecast of a 5% to 13% decline.
2026-05-06
Novo Nordisk: Raised its 2026 earnings forecast, expecting full-year adjusted sales to decline by 4% to 12% year-on-year, up from the previous forecast of a 5% to 13% decline.